Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia

Published:2024-07-15 Issue:1 Volume:29 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Hua Fang¹²,Hu Yue¹³,He Guang-Cui¹,Lai Si-Han¹,He Ying¹,Zhang Shan¹,Deng Yan¹,Han Ying¹,Liu Xiao-Dong²,Yang Kun²,Zhong Hui-Xiu⁴,Xiao Jian²,Zheng Zhong-Zheng⁵,Yi Hai¹^ORCID

Affiliation:

1. Department of Hematology, The General Hospital of Western Theater Command, PLA, Chengdu, People’s Republic of China

2. Department of Hematology, Zigong First People’s Hospital, Zigong, People’s Republic of China

3. North Sichuan Medical College Graduate School, Nanchong, People’s Republic of China

4. Department of Laboratory Medicine, Zigong First People’s Hospital, Zigong, People’s Republic of China

5. Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, People’s Republic of China

Funder

Hospital Management Research Foundation of the General Hospital of Western Theater Command

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2024.2377860

Reference30 articles.

1. Accumulating evidence for a role of p53 in multiple drug resistant Acute Myeloid Leukemia

2. Reactivating hope for TP53-mutated acute myeloid leukaemia?

3. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases

4. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

5. Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site